Prader-Willi syndrome due to imprinting mutation

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Prader-Willi syndrome due to imprinting mutation.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Prader-Willi syndrome due to imprinting mutation.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Voranigo

(vorasidenib)Orphan drugstandard

Servier Pharmaceuticals LLC

Isocitrate Dehydrogenase 1 Inhibitor [EPC]

12.1 Mechanism of Action Vorasidenib is a small molecule inhibitor that targets isocitrate dehydrogenase-1 and 2 (IDH1 and IDH2) enzymes. In vitro, vo...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Prader-Willi syndrome due to imprinting mutation.
Search all trials →
Search clinical trials for Prader-Willi syndrome due to imprinting mutation

Recent News & Research

No recent news articles indexed yet for Prader-Willi syndrome due to imprinting mutation.
Search PubMed for Prader-Willi syndrome due to imprinting mutation

Browse all Prader-Willi syndrome due to imprinting mutation news →

Specialist Network

No specialists currently listed for Prader-Willi syndrome due to imprinting mutation.

View all Prader-Willi syndrome due to imprinting mutation specialists →

Quick Actions